Previous Close | 18.14 |
Open | 18.16 |
Bid | 19.00 x 1300 |
Ask | 19.08 x 800 |
Day's Range | 17.92 - 19.07 |
52 Week Range | 15.02 - 34.36 |
Volume | |
Avg. Volume | 4,881,911 |
Market Cap | 3.141B |
Beta (5Y Monthly) | 1.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -24.68 |
Earnings Date | Feb 20, 2024 - Feb 26, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 22.26 |
In this article, we will look at the 15 countries that have the best doctors in the world. We will also look at the latest trends in the healthcare industry. If you want to skip our detailed analysis, head straight to the 5 Countries That Have The Best Doctors in the World. Rooted in a […]
The COVID-19 shutdowns in 2020 created surging demand for the virtual care services that Teladoc provides. Teladoc Health's shares began to decline in early 2021. Teladoc stock is currently down nearly 30% year to date.
Buying shares of promising growth companies that haven't yet benefited from the rally is a terrific idea because, right now, you can pick up many of these players for a bargain. Teladoc Health's (NYSE: TDOC) revenue and number of visits soared in the triple digits in the early days of the pandemic as patients favored virtual medical visits over going to a doctor's office. Later into the health crisis though, Teladoc saw a slowdown in growth, and at the same time its purchase of Livongo, a chronic care specialist, set it back from its goal of profitability.